Interestingly, 20.45% of the CTs of our series also expressed GATA2, and, contrarily, 74.65% of the GTs expressed NEUROD1. The co-expression of GATA2 in CTs and NEUROD1 in GTs suggests that some of our CTs and GTs could represent the cortico–gonadotroph tumor subtype previously suggested by Cooper et al. [16]. The gene discussed is NEUROD1; the disease is neoplasm.